Conclusion
PE is uncommon in patients who undergo bariatric surgery, but if left
untreated, it increases mortality risk and long-term morbidity. On the
other hand, systemic thrombolytic administration as a standard
therapeutic approach is considered relatively contraindicated in massive
PE that occurs shortly after surgery. Until the development of
sufficient evidence, it is reasonable to approach thromboembolic events
based on the individual and medical team’s discretion.